Columbia St. Mary's
Columbia St. Mary's ""
For Patients & Visitors | Career Opportunities | Contact Us & Locations
Search
Programs & Services
Find a Physician
Events & Classes
News & Press Releases
Giving Opportunities
Disease & Wellness Information
Clinical Trials
Quality and Clinical Excellence
About Columbia St. Mary's

Home > Clinical Trials Search > Active Clinical Trials Search

Active Clinical Trials

Below is a listing of our current research activities. If you are interested in participating in a clinical trial, please call the study contact or contact the Columbia St. Mary's Clinic Trials Office.

Category: Low Back Pain
Sub Category: Leg Pain, Spondylolisthesis, Lumbar Spinal Stenosis

Title: A Prospective, Multi-Center Clinical Study to Assess the Safety and Effectiveness of the Impliant TOPSTM System

Principal Investigator: Stephen Robbins, MD
Facility: Columbia St. Mary's Hospital Columbia

Contact: 414-961-2225


Category: Prostate Cancer
Sub Category: Radiation Therapy

Title: Phase III Protocol of Androgen Suppression (AS) and 3DCRT/IMRT vs. AS and 3DCRT/IMRT Followed by Chemotherapy with Docetaxel and Prednisone for Localized, High-Risk Prostate Cancer (RTOG 0521).

Principal Investigator: Carl Olson, MD
Facility: Columbia St. Mary's Water Tower Medical Commons and Ozaukee Campus

Contact: Debby Baumgarten, RN - 414-291-1517


Category: Cardiovascular Disease
Sub Category: Heart Attack

Title: The IMMEDIATE (Immediate Metabolic Myocardial Enhancement During Initial Assessment and Treatment in Emergency Care) Trial is a NIH National Heart, Lung, Blood Institute sponsored study that is testing whether giving an Intravenous (IV) solution of readily available medications (Glucose, Insulin and potassium), referred to as “GIK” is helpful to patients at the first signs of a heart attack.

Principal Investigator: Thomas Aufderheide, MD
Facility: Columbia St. Mary's Hospitals Milwaukee and Ozaukee

Contact: Research Staff - 414-805-9323


Category: Prostate Cancer
Sub Category: Radiation Therapy

Title: A Phase III Study Comparing Combined External Beam Radiation And Transperineal Interstitial Permanent Brachytherapy With Brachytherapy Alone For Selected Patients With Intermediate Risk Prostatic Carcinoma (RTOG 0232)

Principal Investigator: Carl Olson, MD
Facility: Columbia St. Mary's Water Tower Medical Commons and Ozaukee Campus

Contact: Debby Baumgarten, RN - 414-291-1517


Category: Breast Implants (Silicone Gel)
Sub Category: Breast Reconstruction

Title: Mentor Memory Gel Implant Post Approval Study

Principal Investigator: Harvey Bock, MD, Kenneth Dembny, MD, Lawrence Sterkin, MD
Facility: Columbia St. Mary's Hospitals Milwaukee and Ozaukee

Contact: Angela - 414-443-0033


Category: Peripheral Artery Disease
Sub Category: Critical Limb Ischemia and Severe Claudication

Title: Primary Stent Supported Angioplasty for Treatment of Below Knee Critical Limb Ischemia and Severe Life Style Limiting Claudication

Principal Investigator: Andrew Feiring, MD
Facility: Columbia St. Mary's Hospital Columbia

Contact: Mari Krahn, RN - 414-961-3757


Category: Orthopedics
Sub Category: Knee Replacement

Title: Triathlon Cruciate Retaining (CR) Outcomes Study

Principal Investigator: Joseph Davies, MD
Facility: Columbia St. Mary's Hospital Ozaukee

Contact: Patrick Geiger - 414-276-6000


Category: Stroke
Sub Category: Stroke

Title: AVAIL (Adherence Evaluation After Ischemic Stroke Longitudinal) This study is designed to determine how well patients adhere to therapies ordered to prevent a recurrent stroke over time and to determine why patients may discontinue therapies without medical advice.

Principal Investigator: Jacqueline Carter, MD
Facility: Columbia St. Mary's Hospitals Columbia, Milwaukee and Ozaukee

Contact: Karen McCuaig, RN - 414-291-1218


Category: Low Back Pain
Sub Category: Degenerative Disc Disease

Title: A Prospective, Multicenter, Randomized, Study Comparing the use of HEALOS® to Autograft in a Transforaminal Lumbar Interbody Fusion (TLIF) Approach

Principal Investigator: Max Lee, MD
Facility: Columbia St. Mary's – Columbia, Milwaukee and Ozaukee

Contact: Kelley Farnsworth, PA - 414-438-6500


Category: Cardiovascular
Sub Category: Vascular

Title: Stenting and Angioplasty with Protection in Patients at High-Risk for Endarterectomy - Sapphire WW

Principal Investigator: Andrew Feiring, MD
Facility: Columbia St. Mary's – Columbia and Ozaukee Campus

Contact: Mari Krahn, RN - 414-961-3757


Category: Breast Cancer
Sub Category: Cancer

Title: CALGB 40101: Cyclophosphamide and Doxorubicin (CA 4 Vs 6 Cycles) Versus Paclitaxel (4 Vs 6 Cycles) as Adjuvant Therapy for Breast Cancer in Women with 0-3 Positive Axillary Lymph Nodes: A 2x2 Factorial Phase III Randomized Study

Principal Investigator: Carl Olson, MD
Facility: Prospect Medical Commons and Ozaukee Campus

Contact: Julie Hugg - 414-319-3122


Category: Colon Cancer
Sub Category: Rectal Cancer

Title: CALGB/SWOG 80405: A Phase III Trial of Irinotecan/5-FU/Leucovorin or Oxaliplatin/5-FU/Leucovorin with Bevacizumab, or Cetuximab (C225), or with the Combination of Bevacizumab and Cetuximab for Patients with Untreated Metastatic Adenocarcinoma of the Colon or Rectum

Principal Investigator: Carl Olson, MD
Facility: Columbia St. Mary's – Prospect Medical Commons and Ozaukee

Contact: Julie Hugg - 414-319-3122


Category: Breast Cancer
Sub Category: Cancer

Title: Hormone Therapy With or Without Combination Chemotherapy in Treating Women Who Have Undergone Surgery for Node-Negative Breast Cancer (The TAILORx Trial). Program for the Assessment of Clinical Cancer Tests (PACCT-1): Trial Assigning Individualized Options for Treatment.

Principal Investigator: Carl Olson, MD
Facility: Prospect Medical Commons and Ozaukee Campus

Contact: Julie Hugg - 414-319-3122


Category: Intimate Partner Violence
Sub Category: Intimate Partner Violence

Title: Health Care Can Change from Within

Principal Investigator: L. Kevin Hamberger, Ph.D/ Bruce Ambuel, Ph.D
Facility: Columbia St. Mary's Family Health Center

Contact: Amy Kistner, MS, LPC - 262-928-6953


Category: Cardiovascular
Sub Category: Cardiac Arrest

Title: Prehospital Resuscitation using an Impedance Valve and Early versus Delayed analysis (ROC PRIMED) Trial

Principal Investigator: Tom Aufderheide, MD
Facility: Columbia St. Mary's – Columbia, Milwaukee, Ozaukee Campus

Contact: David Kitscha, MCW - 414-805-2572


Category: Endometrial Cancer
Sub Category: Cancer

Title: A Randomized Phase III Trial Of Doxorubicin/Cisplatin/Paclitaxel/G-CSF Versus Carboplatin/Paclitaxel in Patients with Stage III & IV or Recurrent Endometrial Cancer (GOG 0209)

Principal Investigator: David Boruta, MD
Facility: Columbia St. Mary's Water Tower Medical Commons, Prospect Medical Commons, Ozaukee Campus

Contact: Julie Hugg - 414-319-3122


Category: Head and Neck Cancer
Sub Category: Cancer

Title: RTOG 0522: A Randomized Phase III Trial of Concurrent Accelerated Radiation and Cisplatin versus Concurrent Accelerated Radiation, Cisplatin, and Cetuximab (C225) [Followed by Surgery for Selected Patients] for Stage III and IV Head and Neck Carcinomas

Principal Investigator: Carl Olson, MD
Facility: Columbia St. Mary's Water Tower Medical Commons and Ozaukee Campus

Contact: Debby Baumgarten, RN - 414-291-1517


Category: Prostate Cancer
Sub Category: Cancer

Title: A Phase III Randomized Study of Hypofractionated 3d-CRT/IMRT Versus Conventionally Fractionated 3D-CRT/IMRT in Patients with Favorable-Risk Prostate Cancer (RTOG 0415)

Principal Investigator: Carl Olson, MD
Facility: Columbia St. Mary's Water Tower Medical Commons and Ozaukee Campus

Contact: Debby Baumgarten, RN - 414-291-1517


Category: Prostate Cancer
Sub Category: Cancer

Title: A Phase III Trial of Short Term Androgen Deprivation with Pelvic Lymph Node or Prostate Bed Only Radiotherapy (SPPORT) in Prostate Cancer Patients with a Rising PSA after Radical Prostatectomy (RTOG 0534)

Principal Investigator: Carl Olson, MD
Facility: Columbia St. Mary's Water Tower Medical Commons and Ozaukee Campus

Contact: Debby Baumgarten, RN - 414-291-1517


Category: Lung Cancer (Non-Small Cell Lung Cancer (NSCLC)
Sub Category: Cancer

Title: A Phase III Randomized Trial of Adjuvant Chemotherapy with or without Bevacizumab for Patients with Completely Resected Stage IB (> 4 cm) -IIIA Non-Small Cell Lung Cancer (NSCLC)(ECOG 1505)

Principal Investigator: Charles Tiber, MD
Facility: Columbia St. Mary's Prospect Medical Commons, Water Tower Medical Commons and Ozaukee Campus

Contact: Julie Hugg - 414-319-3122


 
Urgent Care 
Related Topics

Order or View DVDs / Healthcare Subscriptions
Site Map | Disclaimer | Privacy Policy
Copyright © 2008 Columbia St. Mary’s